CN101011519A - Chinese medicine for treating cardiovascular and cerebrovascular disease - Google Patents
Chinese medicine for treating cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN101011519A CN101011519A CN 200610150857 CN200610150857A CN101011519A CN 101011519 A CN101011519 A CN 101011519A CN 200610150857 CN200610150857 CN 200610150857 CN 200610150857 A CN200610150857 A CN 200610150857A CN 101011519 A CN101011519 A CN 101011519A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- cerebrovascular disease
- cardiovascular
- treating cardiovascular
- bulbus allii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a Chinese medicament for treating cardiovascular and cerebrovascular diseases, which is prepared from the following raw materials (by weight portions): pericarpium trichosanthis 20-25%, Bulbus Allii Macrostemonis 15-20%, cinnamon twig 15-20%, polygala root 5-7%, radix salvia miltiorrhiza 10-14%, nutgrass flatsedge rhizome 10-12% and dalbergia wood 10-12%. The medicament can be triturated into capsules or prepared into pills through conventional methods.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease is a kind of common multiple disease, cause of disease complexity, and the disease form of expression is varied, and coronary atherosclerosis, apoplexy, cerebral thrombosis etc. are arranged.At present the Chinese patent medicine of treatment cardiovascular and cerebrovascular vessel based on blood fat reducing, cholesterol reducing, blood vessel dilating, improve cardiac function, clinical common cardiovascular and cerebrovascular vessel medication has FUFANG DANSHEN DIWAN etc., but curative effect is not remarkable.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, short treating period, instant effect, no Drug resistance and toxic and side effects.
Medicine of the present invention is got Fructus Trichosanthis, and moistening the lung and resolving phlegm, eliminating stagnation are opened breast; Bulbus Allii Macrostemonis, the chest stuffiness relieving of regulating the flow of vital energy, activating YANG and eliminating stagnation; Ramulus Cinnamomi, promoting the flow of QI in the collateral by warming the meridian, diaphoresis expelling pathogenic factors from muscles, anti-inflammation and sterilization; Radix Polygalae, the beneficial will of calming the nerves, eliminate the phlegm, resolving depression.Radix Salviae Miltiorrhizae, blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind; Prepared RHIZOMA CYPERI, the resolving depression of regulating the flow of vital energy, pain relieving regulating menstruation; Lignum Dalbergiae Odoriferae, regulating QI to relieve pain, hemostasis, blood stasis dispelling.
Chinese medicine of the present invention is by the crude drug of following weight ratio: Fructus Trichosanthis 20-25%, Bulbus Allii Macrostemonis 15-20%, Ramulus Cinnamomi 15-20%, Radix Polygalae 5-7%, Radix Salviae Miltiorrhizae 10-14%, prepared RHIZOMA CYPERI 10-12%, Lignum Dalbergiae Odoriferae 10-12% pulverize make capsule or routinely preparation method make pill.
The compatible blood circulation promoting and blood stasis dispelling of medicine of the present invention should numbness activate yang through-supplementation.To the treatment heart-yang to shaking, blockage of the cardiac vessels, arrhythmia, myocardial ischemia, the premature beat cerebral blood supply insufficiency, apoplexy, coronary heart disease, the blood thickness, cerebral arteriosclerosis, diseases such as menoxenia have curative effect preferably.
The specific embodiment
Preferably: Fructus Trichosanthis 18g, Bulbus Allii Macrostemonis 15g, Ramulus Cinnamomi 15g, Radix Polygalae 5g, Radix Salviae Miltiorrhizae 10g, prepared RHIZOMA CYPERI 8g, Lignum Dalbergiae Odoriferae 8g make capsule or pill.
Below by clinical observation test, further set forth the beneficial effect of Chinese medicine of the present invention.
1, the present invention treats the clinical experiment report of apoplexy:
Diagnostic criteria: healthy energy loses that void, venation block, muscle arteries and veins muscle are lost and supported, hemiplegia, deflective mouth and eye, blood stagnancy due to deficiency of QI, the slow person of tongue the lung-pulse, reaches hospital and does electroencephalogram or medical certification.
Case is selected: male 80 people, and women 70 people, the age is between 40-70 year.
Therapeutic Method: take Chinese medicine 7-8 capsules of the present invention, every heavy 0.5 gram, or take each 9 grams of pill, 20 days-30 days.
The result: cure 140 people, 8 people that take a turn for the better, invalid 2 people, total effective rate reaches 99%, effect stability.
2, the clinical experiment of treatment by Chinese herbs coronary heart disease of the present invention report:
Diagnostic criteria, the pulse condition knot is felt oppressed for person, cardiopalmus, anterior pectorial region paroxysmal pain person is arranged, and with hospital's color ultrasound report or expert consultation.
Case is selected, male 100 people, women 50 people, maximum 69 years old age, minimal ages 33;
Therapeutic Method: take Chinese medicine 7-8 capsules of the present invention, every heavy 0.5 gram, or take each 9 grams of pill, 20 days-30 days.
Result: cure 137 examples, 10 examples that take a turn for the better, invalid 3 examples, total effective rate 98%, stable curative effect, no longer recurrence.
Claims (2)
1, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that the crude drug by following weight ratio: Fructus Trichosanthis 20-25%, Bulbus Allii Macrostemonis 15-20%, Ramulus Cinnamomi 15-20%, Radix Polygalae 5-7%, Radix Salviae Miltiorrhizae 10-14%, prepared RHIZOMA CYPERI 10-12%, Lignum Dalbergiae Odoriferae 10-12% make capsule or pill.
2, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: Fructus Trichosanthis 18g, Bulbus Allii Macrostemonis 15g, Ramulus Cinnamomi 15g, Radix Polygalae 5g, Radix Salviae Miltiorrhizae 10g, prepared RHIZOMA CYPERI 8g, Lignum Dalbergiae Odoriferae 8g make capsule or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101508577A CN100455313C (en) | 2006-10-05 | 2006-10-05 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006101508577A CN100455313C (en) | 2006-10-05 | 2006-10-05 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101011519A true CN101011519A (en) | 2007-08-08 |
| CN100455313C CN100455313C (en) | 2009-01-28 |
Family
ID=38699359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006101508577A Expired - Fee Related CN100455313C (en) | 2006-10-05 | 2006-10-05 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100455313C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041119A (en) * | 2013-02-04 | 2013-04-17 | 刘学友 | Traditional Chinese medicine for treating cardiac disease |
| CN105596672A (en) * | 2016-01-25 | 2016-05-25 | 陈锦清 | Medicine for treating cardiomyopathy |
| CN111870645A (en) * | 2020-07-09 | 2020-11-03 | 何庆勇 | Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof |
| CN113616723A (en) * | 2021-09-03 | 2021-11-09 | 黑龙江中医药大学附属第二医院 | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof |
-
2006
- 2006-10-05 CN CNB2006101508577A patent/CN100455313C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041119A (en) * | 2013-02-04 | 2013-04-17 | 刘学友 | Traditional Chinese medicine for treating cardiac disease |
| CN103041119B (en) * | 2013-02-04 | 2015-11-18 | 刘学友 | One treats cardiopathic Chinese medicine |
| CN105596672A (en) * | 2016-01-25 | 2016-05-25 | 陈锦清 | Medicine for treating cardiomyopathy |
| CN111870645A (en) * | 2020-07-09 | 2020-11-03 | 何庆勇 | Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof |
| CN113616723A (en) * | 2021-09-03 | 2021-11-09 | 黑龙江中医药大学附属第二医院 | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100455313C (en) | 2009-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991816B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN102228525B (en) | Traditional Chinese medicine for treating cardio-cerebral vascular stagnation | |
| CN1686510A (en) | Ready prepared Chinese medicine for preventing and treating brain apoplexia | |
| CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN100455313C (en) | Chinese medicine for treating cardiovascular and cerebrovascular disease | |
| CN104069446A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN103230457B (en) | A kind of Chinese medicine composition treating viral myocarditis and preparation method thereof and purposes | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103007192A (en) | Chinese medicinal composition for treating thoracic obstruction | |
| CN102908425A (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN102309727B (en) | Chinese patent medicine for facial beautification and longevity | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103495108A (en) | Medicine for treating chronic hypotension and preparation method for medicine | |
| CN102836320B (en) | Chinese medicinal pill for treating tachyarrhythmia | |
| CN103948880B (en) | Traditional Chinese medicine for treating arrhythmia | |
| CN102397391A (en) | Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof | |
| CN102743578B (en) | Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction | |
| CN102389494A (en) | Chinese medicine for treating diabetic heart diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090128 Termination date: 20111005 |